Page last updated: 2024-08-18

pyrroles and Ambulation Disorders, Neurologic

pyrroles has been researched along with Ambulation Disorders, Neurologic in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Healy, ME; Krajewski, KM; Lai, KC; Miksad, RA; Rojas, R; Stein, MC; Zhu, AX1
Barbosa, E; Christie, DK; Pannu, R; Singh, AK; Singh, I1

Other Studies

2 other study(ies) available for pyrroles and Ambulation Disorders, Neurologic

ArticleYear
Imbalance and gait disturbance from tyrosine kinase inhibition in hepatocellular cancer.
    Journal of gastrointestinal cancer, 2009, Volume: 40, Issue:3-4

    Topics: Aged; Antineoplastic Agents; Carcinoma, Hepatocellular; Clinical Trials, Phase III as Topic; Gait Disorders, Neurologic; Hepatitis, Autoimmune; Humans; Indoles; Liver Neoplasms; Male; Postural Balance; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrroles; Sensation Disorders; Sunitinib

2009
Post-trauma Lipitor treatment prevents endothelial dysfunction, facilitates neuroprotection, and promotes locomotor recovery following spinal cord injury.
    Journal of neurochemistry, 2007, Volume: 101, Issue:1

    Topics: Animals; Atorvastatin; Blood-Brain Barrier; Chemotaxis, Leukocyte; Cytokines; Down-Regulation; Endothelial Cells; Female; Gait Disorders, Neurologic; Heptanoic Acids; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Neuroprotective Agents; Paralysis; Pyrroles; Rats; Rats, Sprague-Dawley; Recovery of Function; Regional Blood Flow; rhoA GTP-Binding Protein; Spinal Cord; Spinal Cord Injuries; Terpenes; Treatment Outcome

2007